These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4989215)

  • 21. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
    Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
    Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of guinea pig plasma factors on phagocytosis of Pasteurella pestis. II. Plasma from plague-infected guinea pigs.
    STANZIALE WG; WHITE JD
    J Bacteriol; 1962 Jan; 83(1):182-6. PubMed ID: 13916284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.
    Montminy SW; Khan N; McGrath S; Walkowicz MJ; Sharp F; Conlon JE; Fukase K; Kusumoto S; Sweet C; Miyake K; Akira S; Cotter RJ; Goguen JD; Lien E
    Nat Immunol; 2006 Oct; 7(10):1066-73. PubMed ID: 16980981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of monokines induced by Yersinia pestis EV on the functional activity of neutrophils during development of antiplague immunity].
    Ivanova IA; Vasil'eva GI; Kiseleva AK
    Tsitologiia; 2002; 44(8):799-802. PubMed ID: 12506672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigations on plague foci in Mahasu District of Himachal Pradesh.
    Krishnaswami AK; Rao CK; Chandrahas RK; Samuel D; Ravindran PC
    Indian J Med Res; 1972 Aug; 60(8):1126-31. PubMed ID: 4661463
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J
    Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
    Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
    Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A plant-produced plague vaccine candidate confers protection to monkeys.
    Mett V; Lyons J; Musiychuk K; Chichester JA; Brasil T; Couch R; Sherwood R; Palmer GA; Streatfield SJ; Yusibov V
    Vaccine; 2007 Apr; 25(16):3014-7. PubMed ID: 17287055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plague into the 21st century.
    Butler T
    Clin Infect Dis; 2009 Sep; 49(5):736-42. PubMed ID: 19606935
    [No Abstract]   [Full Text] [Related]  

  • 31. [Some features of action of "murine" toxin and Yersinia pestis antigen fraction I in cells sensitive to animal plague].
    Aseeva LE; Mishan'kin MB; Goncharov EK; Shevchenko LA
    Biull Eksp Biol Med; 1995 Feb; 119(2):193-5. PubMed ID: 7670051
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immune biological studies on Yersinia pseudotuberculosis (Synonym: Pasteurella pseudotuberculosis)].
    Thal E
    Schweiz Arch Tierheilkd; 1966 Jul; 108(7):372-88. PubMed ID: 5927559
    [No Abstract]   [Full Text] [Related]  

  • 33. Construction of defined F1 negative mutants of virulent Yersinia pestis.
    Worsham PL; Stein MP; Welkos SL
    Contrib Microbiol Immunol; 1995; 13():325-8. PubMed ID: 8833864
    [No Abstract]   [Full Text] [Related]  

  • 34. STUDIES ON IMMUNIZATION AGAINST PLAGUE. XVII. EXPERIMENTAL STUDIES ON THE EFFECTIVENESS OF ALUMINUM-HYDROXIDE-ADSORBED FORMALIN-KILLED PASTEURELLA PESTIS.
    CHEN TH; LARSON A; MEYER KF
    J Immunol; 1964 Oct; 93():668-76. PubMed ID: 14219083
    [No Abstract]   [Full Text] [Related]  

  • 35. A filtered non-toxic plague vaccine which protects guinea-pigs and mice.
    Smith H; Packman LP
    Br J Exp Pathol; 1966 Feb; 47(1):25-34. PubMed ID: 5908699
    [No Abstract]   [Full Text] [Related]  

  • 36. THE DETECTION OF INAPPARENT INFECTIONS WITH PASTEURELLA PESTIS IN A MICROTUS CALIFORNICUS POPULATION IN THE SAN FRANCISCO BAY AREA.
    GOLDENBERG MI; QUAN SF; HUDSON BW
    Zoonoses Res; 1964 Apr; 3():1-13. PubMed ID: 14270073
    [No Abstract]   [Full Text] [Related]  

  • 37. [Questions concerning the ecology of plague and pseudotuberculosis microbes. 3. On the fate of plague and pseudotuberculosis bacteria in mixed cultures].
    Bibikova VA; Klassovskiĭ LN; Osadchaia LM; Petrov VS
    Zh Mikrobiol Epidemiol Immunobiol; 1967 May; 44(5):138-9. PubMed ID: 5617963
    [No Abstract]   [Full Text] [Related]  

  • 38. [In vitro selection of P. pestis variants with vaccinal properties].
    Akimovich VV; Nikoaev II; Zykin LF; Ponomarev NG; Popov AA
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Jun; 42(6):64-8. PubMed ID: 5870008
    [No Abstract]   [Full Text] [Related]  

  • 39. Trapping and serum testing of rodents caught prior to the outbreak of plague in Rhodesia.
    Swanepoel R; Blackburn NK; Condy JB
    Cent Afr J Med; 1976 Jul; 22(7):131-3. PubMed ID: 963739
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and epidemiologic notes on a defined outbreak of plague in Vietnam.
    Legters LJ; Cottingham AJ; Hunter DH
    Am J Trop Med Hyg; 1970 Jul; 19(4):639-52. PubMed ID: 5425503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.